An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to benefit from specific therapies, including immunotherapy and stem cell transplantation.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗